Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study
Julien Sénéschal, Alexandra Duplaine, H. Maillard, Thierry Passeron, Nicolas Andreu, R. Lassalle, Clélia Favary, C. Droitcourt, Alain Taı̈eb, Khaled Ezzedine
Topics & Concepts
MedicineTacrolimusVitiligoCalcineurinRandomized controlled trialPlaceboInternal medicineDermatologyTransplantationAlternative medicinePathologymelanin and skin pigmentationDermatologic Treatments and ResearchMast cells and histamine